OTLK

axl_370z

I see what you're saying but OTLK failed to prove drug efficiency while RCKT had a manufacturing issue but they failed twice for the same thing so I don't know how competent they're but that being said they're decreased their workforce by 30% and pulled another drug they were working on to focus on this so maybe........will see im just closely monitoring for now

notbadhowareyou

Ugh getting flashbacks from OTLK.  Everyone was saying there's no way it fails FDA approval a fourth time then stock plummets AH. Hopefully RCKT's management is more competent

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill. - HUBC: $920k cash ($19m cash and receivables) vs a hilarious $129.22m in debt/payables due this year - BNAI: $150k cash and receivables vs $12.31m in debt/payables due this year - BNZI: $850k cash (+1.83m receivables) vs $26.05m in debt/payables due this year

clockworkwarrior

*SCAM ALERT* The Big List of Stupid Balance Sheets - 2026 - impending Bankruptcy Alert   • ⁠NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  • ⁠BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   • ⁠NRXP: *$7m cash and *$30.6 million debt/payables due this year and no way to pay beyond dilution   • ⁠OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  • ⁠MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year. *NRXP recently diluted investors to pay off its debt balance. A very large current liabilities balance still remains.

Your_Answer_Is_No

Here are some examples of commonly posted/pumped stocks will horrendous balance sheets. I anticipate every single one of these companies will massively dilute shareholders within the next 6-12 months in an attempt to stay afloat. I doubt it'll work. NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution BURU: $6.8m cash with $42 million in debt/payables due this year and no way to pay beyond dilution NRXP: *$7m cash and *$30.6 million debt/payables due this year and no way to pay beyond dilution OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely. MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year. *NRXP recently diluted investors to pay off its debt balance. A very large current liabilities balance still remains.

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill. - HUBC: $920k cash ($19m cash and receivables) vs a hilarious $129.22m in debt/payables due this year - BNAI: $150k cash and receivables vs $12.31m in debt/payables due this year - BNZI: $850k cash (+1.83m receivables) vs $26.05m in debt/payables due this year

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill. - HUBC: $920k cash ($19m cash and receivables) vs a hilarious $129.22m in debt/payables due this year - BNAI: $150k cash and receivables vs $12.31m in debt/payables due this year - BNZI: $850k cash (+1.83m receivables) vs $26.05m in debt/payables due this year

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill. - HUBC: $920k cash ($19m cash and receivables) vs a hilarious $129.22m in debt/payables due this year   - BNAI: $150k cash and receivables vs $12.31m in debt/payables due this year

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill. - HUBC: $920k cash ($19m cash and receivables) vs a hilarious $129.22m in debt/payables due this year   - BNAI: $150k cash and receivables vs $12.31m in debt/payables due this year

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill. - HUBC: $920k cash ($19m cash and receivables) vs a hilarious $129.22m in debt/payables due this year

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill. - HUBC: $920k cash ($19m cash and receivables) vs a hilarious $129.22m in debt/payables due this year

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill. - HUBC: $920k cash ($19m cash and receivables) vs a hilarious $129.22m in debt/payables due this year

notbadhowareyou

Sheesh NUAI I remember that phoney lawsuit bringing NUAI down to the 2s and thought it was undervalued. Then i got caught up with that OTLK hype. Could've doubled my money by now

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill. - HUBC: $920k cash ($19m cash and receivables) vs a hilarious $129.22m in debt/payables due this year 

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill. - HUBC: $920k cash ($19m cash and receivables) vs a hilarious $129.22m in debt/payables due this year

notbadhowareyou

Yup, i said the same thing about RVPH and OTLK and lost 7500USD. Not fun. It is what it is, live and learn.

BodybuilderWorried30

Yeah same, decided to sell my IBRX and managed to recover my loss from OTLK...don't want to get an stress ulcer with biotech again over a holiday. Even though was tempted to hold...

REEMFMetalHead

Just picked up OTLK, at .5479

clockworkwarrior

LMAO more dilutive debt. Ontop of: The Big List of Stupid Balance Sheets - 2026 - impending Bankruptcy Alert   • ⁠NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  • ⁠BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   • ⁠NRXP: *$7m cash and *$30.6 million debt/payables due this year and no way to pay beyond dilution   • ⁠OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  • ⁠MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year. *NRXP recently diluted investors to pay off its debt balance. A very large current liabilities balance still remains.

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill.

No_Cell6708

I'm not sure what to tell you at this point lol. I will just plug my usual copy+paste. Be careful with holding any of these guys for any meaningful amount of time The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill.

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill.

ElmoLovesGrover

Yeah, that initial dump when it hit very close to $3 about 7:30 am was the time to get in for a day trade. Congrats on that. Reminds me of the guy on here who bought the OTLK New Years Eve post-market crash at 30 cents and sold minutes later at 45 cents. He would have been even better had he held this the next trading day (Jan 2) when it almost touched 70 cents! Point is -playing the overreeaction to the downside on these small biotechs is a darn profitable play.

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill.

ElmoLovesGrover

My bags: 1. VSEE - down 51%. Have not averaged down so extra loss 2. OTLK - down 35%. Averaged down; small loss by dollar value 3. ARBE - down 35%. Averaged down. 4. MOBX - down 26%; Averaged down; my most disappointing bag. I genuinely believed in the company. Reasons for hope: 1. Am currently up 35% on my April DPRO $7.50 calls. First purchased Nov. 3, averaged down. Was at one point down a staggering 70%! 2. Currently up 5% on PRZO after being down something like 30%. With $14,000 invested being down 30% hurt.

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   - ASBP: $1.95m in cash and $13.86m in debt/payables due this year - SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively I floated by goodwill.

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   -ASBP: $1.95m in cash and $13.86m in debt/payables due this year -SMX: $750k cash vs $22.25 million in debt/payables due this year. Total assets massively inflated by goodwill.

ElmoLovesGrover

The VP news says to me they re lookign for a buyout, or partnership. Look at that that gals background and the consider the timing of her hire. They are seeking a partnership or buyout from big biotech or pharma. This could involve dilution, or they could instead give up a big chunk of any profits from US sales of the eye drug in exchange for someone else funding whatever the heck it is FDA wants from them. Best case still remains they find out what exactly what it is FDA wants and it turns out to something very minor, like presenting the data in different way, or analyzing it in a different way, and it costs OTLK little time or money to provide what FDA says they want (again).

bslaven3

I know OTLK is possibly circling the drain, but they're up 10% today. Any news other than the new VP of Corporate Strategy?

No_Cell6708

The Big List of Stupid Balance Sheets.   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and **$32 million current liabilities due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.   **Was $41m, but they diluted to pay off debt

No_Cell6708

REMINDER! The Big List of Stupid Balance Sheets - 2026 - impending Bankruptcy Alert   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: *$7m cash and *$30.6 million debt/payables due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year. *NRXP recently diluted investors to pay off its debt balance. A very large current liabilities balance still remains.

No_Cell6708

There are so many every day that I've genuinely gotten bored of reposting lol The Big List of Stupid Balance Sheets - 2026 - impending Bankruptcy Alert   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: *$7m cash and *$30.6 million debt/payables due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year. *NRXP recently diluted investors to pay off its debt balance. A very large current liabilities balance still remains.

QNCJohn

QNC will probably swing $0.25 down with no news then close flat at $5. Waiting for news before it gets bigger legs and uplisted Hope to ride the OKLO and SLS trains up. Made a good chunk on both today Will grab some SRXH and OTLK cheapies

Ok-Macaron9014

Why's OTLK pumping?

No_Cell6708

Good post. As a fellow scam hater, I feel this is an appropriate place to share my Big List of Stupid Balance Sheets: The Big List of Stupid Balance Sheets - 2026 - impending Bankruptcy Alert   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and $41 million debt/payables due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.

heyjarsh

ASBP looks like it's going to dump like OTLK Out

Celestial_Surfing

Pretty sure it’ll be after hours, and halts involved. I’m in for a smaller position than what I had on OTLK 🥵

Celestial_Surfing

Mine shows I bought the top. OTLK 2.0? 😭

No_Cell6708

NXXT shills out in full force again today. Don't forget.. The Big List of Stupid Balance Sheets - 2026 - impending Bankruptcy Alert   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and $41 million debt/payables due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.

No_Cell6708

The Big List of Stupid Balance Sheets - 2026 - impending Bankruptcy Alert   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and $41 million debt/payables due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.

No_Cell6708

The Big List of Stupid Balance Sheets - 2026 - impending Bankruptcy Alert   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and $41 million debt/payables due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year.

No_Cell6708

The Big List of Stupid Balance Sheets - 2026 - Update 1   - NXXT: $650k cash with $35 million debt/payables due this year and no way to pay beyond dilution  - BURU: $6.8m cash with $42 million in debt/payables  due this year and no way to pay beyond dilution   - NRXP: $7m cash and $41 million debt/payables due this year and no way to pay beyond dilution   - OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.  - MNTS: $670k in cash with a whopping $17.3 million in debt/payables due this year. 

Ok-Macaron9014

Glad my OTLK sell didnt go through, slightly clawing back some of my massive loss.

Celestial_Surfing

I don’t think I’ll be getting in it again. I doubled down at .35 and sold at .55. Totaled a 19,400 loss… my worst realized loss ever. I had similar with LUNR, but that popped back. I don’t have as much conviction either OTLK

Celestial_Surfing

20k shares of OTLK at 1.66.

ntongh2o

The bottom would be after a FDA rejection of the drug. Happened to multiple other biotechs lately. Instantly dropped 50% or more. OTLK and RVPH

NoRhubarb2277

OTLK for premarket in my opinion on Friday. They don’t have a RS approved, lots of buying volume came in towards the end of AH today. I think we see this to .7

tocompose

I saw someone on Stocktwits made 300% with puts with a strike price of 0.40 cents on OTLK not sure when they bought them though

ElmoLovesGrover

I wonder if I could have even bought put options yesterday or today? I bought SLS puts a month ago to hedge there since my position in SL (unlike my OTLK position) is pretty large. Was able to buy SLS puts a month ago no issue, but when I tried at get more SLS puts yesterday it was a no go. SLS is crazily heavily shorted now.

tocompose

When OTLK dumped to $1.30 or whatever it was premarket, the call option prices didn't dump that much. This gave a false confidence after it was noted that call option prices didn't dump that much with MIST on the last day either. And it was just market manipulation. So that throws the strong option price theory away. I couldn't even buy the call options I wanted. No one was lowering the prices even in the last minutes. People were firm with their option prices. My buy order was ready to go all in. It looks like the news was leaked on both this and CORT also

ElmoLovesGrover

That's a play for sure. If OTLK gives up on US approval and doesn't try to fund yet another Phase 3, then their cash burn rate will drop dramatically. They still have very little cash on hand though, and UK EU sales aren't going to bring in enough cash, especially during the current ramp up phase (just starting selling there in June). Best case is that after the holidays OTLK can respond to FDA respectfully asking for more details about just what it is they need (and find a way to politely remind them that OTLK just ran another trail giving what they said they wanted!). Best case is FDA comes back with some minor request that is easy for OTLK to meet. Truth is though, FDA is a Federal Gov. regulatory agency. They literally don't have to give OTLK any specifics at all. If they want to keep on saying "We want confirmatory evidence.", without saying exactly what they mean, they can do that and there is nothing OTLK can do.

Due-Papaya-6217

OTLK now would be a good buy (if your buy order goes through lol), they still have the EU and UK market. Don’t panic sell yet it should get back to the 70s IMO

ElmoLovesGrover

I doubt it. I'm sure OTLK folks are looking to see if they have any options, but are likely as confused as we are: you got a sense of that in the press release when they noted that FDA "*did not specify what evidence would be acceptable"* OTLK people are like: "WTF!? We did what you wanted and it didn't change a thing!"

stevenryl866

OTLK - well I got the dip 0.38x now +45% lol

InterestingMinute972

So OTLK's rejection letter does not read like an outright rejection? More like FDA going back on their own wards? Is there any chance of a reversal?

Correct-Court-8837

Anyone else’s market order to sell OTLK taking forever to fill?

NoRhubarb2277

I think .30 is the bottom for OTLK, might jump in for a dead cat bounce

ElmoLovesGrover

Yes it will. 70-90% tankage. Will be below a quarter at least. Was a small play for me, but I'm just so annoyed that FDA didn't even give them a reason. Instead said the same damn thing they said before, as if OTLK didn't just run an additional trial (approved by FDA) to address that.

Mammoth-Land-3515

Glad I went with my gut on OTLK. Told you I had a bad feeling. Dang.

ElmoLovesGrover

This OTLK drug is already approved in both UK and EU, but the flippin' FDA.... https://preview.redd.it/nrd88to1zlag1.png?width=342&format=png&auto=webp&s=6069a3f1beae8854606c909748a18052010fd17d

ElmoLovesGrover

It is f---ed up. Last time FDA said they wanted confirmatory evidence. So OTLK designed a trial, got the trial approved by FDA's SPA process, and then ran the trial. They did the damn trail FDA wanted, and FDA still rejects citing the same damn thing they cited last time. Thats one of the drawbacks about biotech investing: FDA can be a crapshoot.

ElmoLovesGrover

OTLK: Yes, it will tank. They don't have the funds for another trial. Most annying thing is that FDA gave as their reason they had trial that shopwed efficacy, btu they wanted confirmatory evidence. That is totally F---ed up because FDA said the same thing last time and so OTLK got a Phase 3 trial protocol approved by the FDA Special Protocol Assessment Process, then ran that trial. Then FDA comes back after that trial has been run and says the same damn thing they said before!!

stevenryl866

OTLK - another CRL, lucky me that I have small amount in it. I have low confidence they will get the approval, just buying in for the ride

Ok-Macaron9014

How long can this halt on OTLK last?

ElmoLovesGrover

OTLK received Complete Response letter. **Rejected**.

Due-Papaya-6217

Not in OTLK but I hope it gets approval and wipes out the shorts

Ok-Macaron9014

OTLK, FFA non-approval, this ia going to tank

Correct-Court-8837

OTLK: https://ir.outlooktherapeutics.com/news-releases/news-release-details/outlook-therapeutics-provides-regulatory-update-us-food-and-0

ElmoLovesGrover

OTLK: https://preview.redd.it/81k14xaovlag1.png?width=218&format=png&auto=webp&s=f1ca3e76ff57563d2045a320c938952101807745

WishOk462

Congratulations to everyone that got in on OTLK.

WishOk462

OTLK halted. This is going to the moon.

SignificanceLate7002

OTLK halted

bslaven3

OTLK approval gonna be AH? Don’t like that

Mammoth-Land-3515

OTLK just gives me a bad feeling. Gonna just sit back and watch what happens. Hoping whoever is holding them gets good news though!

No_Cell6708

- OTLK: $11m cash and receivables vs $46 million in current debt/payables due this year. No revenue to speak of. Dilution likely.

stevenryl866

https://preview.redd.it/49pmgj69glag1.png?width=2028&format=png&auto=webp&s=213d1c659cfcd4a16d3996e32f7324b1c2d3d306 OTLK - waiting for PDUFA outcome, small amount in it and joining the ride.

stevenryl866

https://preview.redd.it/dmpvkpclflag1.jpeg?width=208&format=pjpg&auto=webp&s=91e7a16af805bd50d628defb7a3acb18e6cafbfd OTLK - still waiting for PDUFA outcome, small amount in it just for the ride

ElmoLovesGrover

I feel the MIST vibe too unfortunately. OTLK did not run up prior to PDUFA day though. Expectation is that it is not going to be approved so no pre-announcement run-up. If it tanks will be because it was not approved. If approved it should run as most are not expecting approval.

SignificanceLate7002

Volume just picked up on an upswing for OTLK.

Ok-Macaron9014

OTLK!

headhoncho4

OTLK been plugging along all day after this morings dump

Little-Appearance376

and they turned out to be "garbage". MIST, OTLK, RVPH. I have been wrong as well. NUAI was just an easy call man, not some biotech buy the hype sell the news garbage.

ElmoLovesGrover

Yeah, nothing is jumping out for me today. Premarket averaged down a bit on OTLK and opened small position on NRXP (300 shares at $2.73) but nothing else, and may not do anything else.

bslaven3

I don’t know if I’ll touch anything today. Market seems to be too sketchy for my taste. I’m holding OTLK for good news and still have some turds like NXXT and DVLT that I’m just hoping to break even on at this point or at minimum only lose 10-15%. Good luck today folks! Happy new year!!

Little-Appearance376

Good luck with OTLK y'all, I wouldn't put a dollar into that dog turd. I think it drops to 70-80c. post announcement. Like I have said once before, regardless on if its good or bad news, biotech pennies highly discussed drop. Plus this is their 3rd time trying to get approved. Last time this stock dropped from 2+ to .60c because their shit got whacked.

No-Shoe-3960

Does anyone know when OTLK announcement is?

Due-Papaya-6217

People are confident that OTLK won’t get approved (with good reason) but it would be so funny if it was. So shorted that the squeeze would be incredible. Would actually wipe a lot of people out. Let’s see what happens!

ElmoLovesGrover

OTLK news probably won't be until mid-afternoon at earliest is my guess.

ElmoLovesGrover

Picked up 200 more OTLK. Now have 700 shares at average of $1.90 in play for FDA decision expected today. Don't know if will get approved or not, but not so spooked by the premarket drop. Big fluctuations happen in these little biotechs adjacent to PDUFA dates (see recent MIST for example).

DataExternal4451

CORT bad news, unlucky to holders. Awaiting OTLK news now

Uplipht

Yeah I am probably going to stay away from OTLK. Although I do think it’s a decent play especially if you buy this morning’s dip. Definitely one that you will have to watch closely in pre-market because negative news could push it below $1.

Fun-Record7987

Sounds plausible. At least if I compare with the OTLK reaction that is usually underwhelming 

headhoncho4

Caught that OTLK dip. Hopefully it keeps going.

captain_casino

OTLK is a biopharma pennystock expecting FDA news today. Volatile price swings shouldn't be surprising anybody lol

Splendid_muralist

Someone knows something about OTLK!? Did they not get approval - again?!

ImpressiveDegree5207

OTLK - Today is the expected date for their FDA decision

AdventurousPlum8359

Gonna keep playing on SOPA until it breaks 4ish and gambling 50 bucks on OTLK, after RVPH I'm iffyer on biopharm so not going deep but I don't mind losing 25 vs making 50-100 if it goes through. Otherwise holding some UGRO and AKAN hoping they bounce back soon. I bought fairly low so I'm not down much but definitely expected them to go up after good news lol

AdventurousPlum8359

Fack probably 🙃 time for me to eat that loss and gamble the rest on SOPA or OTLK tonight haha

bslaven3

OTLK isn’t moving. I hope it does but it consistently lets me down

RaZE___SoViEt

Premarket Watchlist: **$ULY** **$ASBP** **$ISPC** **$IVP** **$SRXH** : added more to my position here today : Eric Jackson promoted, **Dec-30** : 10M digital assets: https://finviz.com/news/264149/srx-health-solutions-deploys-initial-10-million-into-several-digital-assets-predominantly-bitcoin-and-ethereum **$DVLT** : CES 2026 presentation jan 6-9 : https://finance.yahoo.com/news/datavault-ai-dvlt-showcases-wisa-203000574.html **$OTLK** & **$SLS** : Needs to release Data